Dosidal · Belgium

Hexabrix 320 mg I/ml

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketBelgium
Recordbe:presentation:cti:115245-01 (version 1)
Levelpresentation
Pack codebe-cnk (Belgian national): 0808469
Identifiersbe-cti-extended: 115245-01
be-cnk: 0808469
be-authorisation: BE115245
Source authorityFAMHP
Read date2026-11-15T03:58:09Z
authorisation statusamp_status: REVOKED
ampp_status: REVOKED
commercialised_now: False
lifecycle: history
period_from: 1980-01-01
supply_problem_now: False
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
controlled status
state: unknown
identityamp_code: SAM115245-00
atc: V08AB03
authorisation_number: BE115245
cti_extended: 115245-01
form: Solution for injection
holder: Guerbet
medicine_type: ALLOPATHIC
name: Hexabrix 320 mg I/ml
pack: 100 ml
parallel_circuit: 0
parallel_import: False
substances: strength: 393.0000 mg/mL
substance: Ioxaglate Meglumine; strength: 196.5000 mg/mL
substance: Sodium Ioxaglate
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
pack product codecnk_public: 0808469
fmd_in_scope: False
note: no FMD product code in SAM for this pack: the maker's GTIN is not published
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
prescription classas_published: Medical prescription - Art 6, §1 bis, 2nd paragraph, 1st indent Law 25/03/1964 + Art 61 Royal Decree 14/12/2006
class: prescription
delivery_modus: M1
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
zuCgz2GFEdmH0vNZF0JhhpD3vRDzk3ldSIbnifZBthtWK9qd733hK19GLa565Ji-QSuuZsaat3Dq-apx6Ae23w
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

Dosidal